Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03255408Phase 2Recruiting
Phase 2, randomised, double-blind trial in obstructive sleep apnea (OSA) (4 arms), sponsored by University of Calgary. Primary endpoints: Changes in cerebral blood flow and ventilatory chemoreflexes at 18 months and Cerebral blood flow responses and ventilatory chemoreflexes during sleep at 18 months. Started Jan 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03255408.